Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Sodium Pyruvate for COPD
NCT00262613Phase 2Completed
- Sponsor
- EmphyCorp Inc.
- Start
- Sep 2004
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Sodium Pyruvate with Placebo (2 arms). Primary endpoints: Lung function as determined by spirometry and Safety as determined by laboratory analyses. Started Sep 2004; status: completed.
02
Drugs
sodium pyruvate nasal spray
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00262613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262613.